UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

The New England journal of medicine, 2016-06, Vol.374 (23), p.2222-2234

2016

Volltextzugriff (PDF)

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial

American journal of respiratory and critical care medicine, 2017-05, Vol.195 (9), p.1189-1197

2017

Volltextzugriff (PDF)

Indacaterol/Glycopyrronium Reduces Moderate or Severe Exacerbations Compared With Salmeterol/Fluticasone, Irrespective of Number of Exacerbations in Previous Year: Indirect Comparison From FLAME and LANTERN Studies

Chest, 2016-10, Vol.150 (4), p.1317A-1317A

2016

Volltextzugriff (PDF)

FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2015-11, Vol.192 (9), p.1068-1079

2015

Volltextzugriff (PDF)

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10 (Issue 1), p.1015-1026

2015

Volltextzugriff (PDF)

Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly

The New England journal of medicine, 2003-11, Vol.349 (22), p.2108-2115

2003

Volltextzugriff (PDF)

Interpreting Evaluating Respiratory Symptoms TM in COPD Diary Scores in Clinical Trials: Terminology, Methods, and Recommendations

Chronic obstructive pulmonary diseases, 2022-10, Vol.9 (4), p.576

2022

Volltextzugriff (PDF)

Interpreting Evaluating Respiratory SymptomsTM in COPD Diary Scores in Clinical Trials: Terminology, Methods, and Recommendations

Chronic obstructive pulmonary diseases, 2022-10, Vol.9 (4), p.576-590

2022

Volltextzugriff (PDF)

Interpreting Evaluating Respiratory Symptoms™ in COPD Diary Scores in Clinical Trials: Terminology, Methods, and Recommendations

Chronic obstructive pulmonary diseases, 2022-01, Vol.9 (4), p.576-590

2022

Volltextzugriff (PDF)

The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia

Obstetrics and gynecology (New York. 1953), 2001-12, Vol.98 (6), p.1109-1116

2001

Volltextzugriff (PDF)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.339-349

2017

Volltextzugriff (PDF)

Interpreting Evaluating Respiratory Symptoms™ in COPD Diary Scores in Clinical Trials: Terminology, Methods, and

Chronic obstructive pulmonary diseases, 2022, Vol.9 (4), p.576-590

2022

Volltextzugriff (PDF)

Self‐Designing Two‐Stage Trials to Minimize Expected Costs

Biometrics, 2002-06, Vol.58 (2), p.432-438

2002

Volltextzugriff (PDF)

Reply to Cooper et al.: The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2018-04, Vol.197 (7), p.968-969

2018

Volltextzugriff (PDF)

The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease/Reply

American journal of respiratory and critical care medicine, 2018-04, Vol.197 (7), p.967-969

2018

Volltextzugriff (PDF)

Aspirin for Primary Prevention of Cardiovascular Events

Journal of general internal medicine : JGIM, 1998-12, Vol.13 (12), p.824-835

1998

Volltextzugriff (PDF)

Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?

American journal of respiratory and critical care medicine, 2017-11, Vol.196 (9), p.1230-1231

2017

Volltextzugriff (PDF)

What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?/Reply

American journal of respiratory and critical care medicine, 2017-11, Vol.196 (9), p.1229-1231

2017

Volltextzugriff (PDF)

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The Cardiovascular Health study

Circulation (New York, N.Y.), 2003-07, Vol.108 (2), p.166-170

2003

Volltextzugriff (PDF)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study

International journal of chronic obstructive pulmonary disease, 2018-01, Vol.13, p.1125-1134

2018

Volltextzugriff (PDF)

Use of the Evaluating Respiratory Symptoms™ in COPD as an Outcome Measure in Clinical Trials: A Rapid Systematic Review

Chronic obstructive pulmonary diseases, 2021-10, Vol.8 (4), p.551-571

2021

Volltextzugriff (PDF)

Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study

Chronic obstructive pulmonary diseases, 2016-08, Vol.3 (4), p.716-728

2016

Volltextzugriff (PDF)

Incidence and predictors of coronary heart disease among older African Americans: The cardiovascular health study

Journal of the National Medical Association, 2001-11, Vol.93 (11), p.423-429

2001

Volltextzugriff (PDF)

Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet

Journal of clinical pharmacology, 2007-12, Vol.47 (12), p.1521-1531

2007

Volltextzugriff (PDF)

CHARACTERISTICS OF PATIENTS USING FIBRINOLYTIC MEDICINE - ALTEPLASE TREATING ACUTE ISCHEMIC STROKE

Tạp chí Y học Cộng đồng, 2021-07, Vol.62 (5)

2021

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(63)
Life Sciences & Biomedicine
(52)
Humans
(44)
Male
(29)
Female
(28)
Aged
(26)
Middle Aged
(23)
Mortality
(21)
Adult
(16)
Physical Sciences
(15)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Patients
(14)
Public, Environmental & Occupational Health
(14)
Risk Factors
(14)
Hong Kong - Epidemiology
(13)
Environmental Sciences
(11)
Environmental Sciences & Ecology
(11)
General & Internal Medicine
(11)
Hong Kong
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial

Indacaterol/Glycopyrronium Reduces Moderate or Severe Exacerbations Compared With Salmeterol/Fluticasone, Irrespective of Number of Exacerbations in Previous Year: Indirect Comparison From FLAME and LANTERN Studies

FLIGHT1 and FLIGHT2: Efficacy and Safety of QVA149 (Indacaterol/Glycopyrrolate) versus Its Monocomponents and Placebo in Patients with Chronic Obstructive Pulmonary Disease

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

Lp(a) Lipoprotein, Vascular Disease, and Mortality in the Elderly

Interpreting Evaluating Respiratory Symptoms TM in COPD Diary Scores in Clinical Trials: Terminology, Methods, and Recommendations

Interpreting Evaluating Respiratory SymptomsTM in COPD Diary Scores in Clinical Trials: Terminology, Methods, and Recommendations

Interpreting Evaluating Respiratory Symptoms™ in COPD Diary Scores in Clinical Trials: Terminology, Methods, and Recommendations

The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Interpreting Evaluating Respiratory Symptoms™ in COPD Diary Scores in Clinical Trials: Terminology, Methods, and

Self‐Designing Two‐Stage Trials to Minimize Expected Costs

Reply to Cooper et al.: The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease

The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease/Reply

Aspirin for Primary Prevention of Cardiovascular Events

Reply: What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?

What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled Corticosteroid Responsiveness in Patients with Chronic Obstructive Pulmonary Disease?/Reply

C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The Cardiovascular Health study

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study

Use of the Evaluating Respiratory Symptoms™ in COPD as an Outcome Measure in Clinical Trials: A Rapid Systematic Review

Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study

Incidence and predictors of coronary heart disease among older African Americans: The cardiovascular health study

Effects of Etoricoxib and Comparator Nonsteroidal Anti-Inflammatory Drugs on Urinary Sodium Excretion, Blood Pressure, and Other Renal Function Indicators in Elderly Subjects Consuming a Controlled Sodium Diet

CHARACTERISTICS OF PATIENTS USING FIBRINOLYTIC MEDICINE - ALTEPLASE TREATING ACUTE ISCHEMIC STROKE

Suchergebnisse filtern